The Scale of the Problem
India has 72 million diagnosed diabetics and another 17 million who don't know they have it. With only 700 endocrinologists and 10,000 diabetologists to serve this population, the doctor-patient ratio is fundamentally broken. Dr. Bhograj explains how technology must fill the gap — not replace doctors, but extend their reach between clinic visits.
The Core Problem
3-Minute Consultations
Doctors spend 3–5 minutes per patient. There's no time for lifestyle assessment, dietary review, or understanding daily glucose patterns. Treatment decisions become "educated assumptions" based on a single HbA1c reading every 3 months.
AI Between Visits
The 7Sugar platform integrates CGM sensors, activity tracking, and lifestyle data. Between visits, AI monitors patients and generates actionable reports — so when the doctor opens the file, problem areas are already flagged.
"We have 72 million diabetics and roughly 700 specialist endocrinologists. The math simply doesn't work. Technology isn't replacing the doctor — it's giving the doctor superpowers between the 3-minute windows they have."
— Dr. Abhijit Bhograj, Co-founder & CMO, 7SugarReal-World Impact
Dr. Bhograj describes treating a 47-year-old gestational diabetes patient during the COVID-19 pandemic using remote monitoring. Despite the high-risk nature of the case — gestational diabetes with complications — the entire pregnancy was managed successfully through the 7Sugar platform, with real-time CGM data enabling timely medication adjustments without in-person visits.
Key Learnings
Scale Demands Technology
With 100,000 patients per endocrinologist, India's diabetes burden cannot be addressed through traditional care models alone. AI-powered monitoring between visits is the only way to scale specialist-quality care.
Data Replaces Assumptions
When a doctor sees a patient for 3 minutes every 3 months, they're making 90 days of treatment decisions based on one number (HbA1c). CGM + AI gives them the full picture — every spike, every pattern, every missed meal.
Pandemic-Proof Care
COVID proved that remote monitoring isn't a convenience — it's a necessity. High-risk patients like gestational diabetes cases need continuous oversight that digital therapeutics can provide regardless of lockdowns.